Manulife (Manufacturers Life Insurance)
NKTR icon

Manulife (Manufacturers Life Insurance)’s Nektar Therapeutics NKTR Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-4,324
Closed -$44.1K – 2971
2025
Q1 		$44.1K Sell
4,324
-14
-0.3% -$183 ﹤0.01% 2843
2024
Q4 		$60.5K Sell
4,338
-77
-2% -$1.36K ﹤0.01% 2916
2024
Q3 		$86.1K Buy
+4,415
New +$84.2K ﹤0.01% 2896
2023
Q2 		– Sell
-4,867
Closed -$51.3K – 3024
2023
Q1 		$51.3K Hold
4,867
– – ﹤0.01% 2856
2022
Q4 		$165K Buy
4,867
+27
+0.6% +$1.31K ﹤0.01% 2645
2022
Q3 		$232K Sell
4,840
-164
-3% -$9.76K ﹤0.01% 2487
2022
Q2 		$285K Buy
+5,004
New +$316K ﹤0.01% 2432
2021
Q4 		– Sell
-14,108
Closed -$3.8M – 3155
2021
Q3 		$3.8M Buy
14,108
+800
+6% +$192K ﹤0.01% 1332
2021
Q2 		$3.42M Sell
13,308
-318
-2% -$88K ﹤0.01% 1421
2021
Q1 		$4.09M Sell
13,626
-789
-5% -$246K ﹤0.01% 1340
2020
Q4 		$3.68M Sell
14,415
-1,217
-8% -$314K ﹤0.01% 1339
2020
Q3 		$3.89M Sell
15,632
-275
-2% -$86.5K ﹤0.01% 1203
2020
Q2 		$5.35M Sell
15,907
-893
-5% -$279K 0.01% 1088
2020
Q1 		$4.5M Buy
16,800
+340
+2% +$105K 0.01% 1058
2019
Q4 		$5.33M Buy
16,460
+5,159
+46% +$1.5M 0.01% 1160
2019
Q3 		$3.04M Buy
11,301
+600
+6% +$220K ﹤0.01% 1293
2019
Q2 		$5.71M Sell
10,701
-791
-7% -$397K 0.01% 1124
2019
Q1 		$5.79M Buy
11,492
+12
+0.1% +$7.11K 0.01% 1139
2018
Q4 		$5.66M Sell
11,480
-276
-2% -$167K 0.01% 1080
2018
Q3 		$10.7M Buy
11,756
+167
+1% +$143K 0.01% 840
2018
Q2 		$8.49M Sell
11,589
-6,291
-35% -$7.25M 0.01% 973
2018
Q1 		$28.5M Buy
17,880
+10,383
+138% +$13.4M 0.03% 478
2017
Q4 		$6.72M Sell
7,497
-9
-0.1% -$5.32K 0.01% 1082
2017
Q3 		$2.7M Sell
7,506
-118
-2% -$36.9K ﹤0.01% 1348
2017
Q2 		$2.23M Buy
7,624
+246
+3% +$71.1K ﹤0.01% 1414
2017
Q1 		$2.6M Sell
7,378
-5,025
-41% -$1.13M ﹤0.01% 1348
2016
Q4 		$2.28M Buy
12,403
+1,879
+18% +$382K ﹤0.01% 1349
2016
Q3 		$2.71M Sell
10,524
-26
-0.2% -$6.7K ﹤0.01% 1308
2016
Q2 		$2.25M Sell
10,550
-848
-7% -$190K ﹤0.01% 1336
2016
Q1 		$2.32M Buy
11,398
+5,643
+98% +$1.08M ﹤0.01% 1367
2015
Q4 		$1.45K Sell
5,755
-6,909
-55% -$1.42M ﹤0.01% 1475
2015
Q3 		$2.08K Buy
12,664
+7,128
+129% +$1.26M ﹤0.01% 1368
2015
Q2 		$1.04K Sell
5,536
-59
-1% -$10.2K ﹤0.01% 1667
2015
Q1 		$923 Buy
5,595
+217
+4% +$44.6K ﹤0.01% 1733
2014
Q4 		$1.25K Sell
5,378
-126
-2% -$26.9K ﹤0.01% 1463
2014
Q3 		$996 Buy
5,504
+140
+3% +$26.8K ﹤0.01% 1566
2014
Q2 		$1.03M Sell
5,364
-878
-14% -$155K ﹤0.01% 1562
2014
Q1 		$1.13K Buy
6,242
+371
+6% +$73.4K ﹤0.01% 1550
2013
Q4 		$1K Buy
5,871
+34
+0.6% +$5.48K ﹤0.01% 1597
2013
Q3 		$915 Sell
5,837
-161
-3% -$29.8K ﹤0.01% 1613
2013
Q2 		$1.04M Buy
+5,998
New +$920K ﹤0.01% 1453

Other funds holding NKTR

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s NKTR Position: Q2 2025 in Review

Manulife (Manufacturers Life Insurance) sold out of Nektar Therapeutics (NKTR) in Q2 2025, closing a stake of 4,324 shares — an estimated $44.1K sold.

Manulife (Manufacturers Life Insurance) first reported a position in NKTR in Q2 2013 and held it in 41 quarters. The position peaked at $28.5M in Q1 2018. 109 funds tracked by Wall St. Rank hold NKTR as of Q2 2025.

  • Manulife (Manufacturers Life Insurance) reported no remaining Nektar Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 4,324 Nektar Therapeutics shares in Q2 2025, an estimated $44.1K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Nektar Therapeutics in Q2 2013 and held it in 41 quarters.
  • Manulife (Manufacturers Life Insurance)'s Nektar Therapeutics position peaked at $28.5M in Q1 2018.
  • 109 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q2 2025.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2025, filed 14 Aug 2025.